<div id="readability-page-1">Chip sector momentum: Intel and Micron rallied on analyst upgrades, AI demand drivers, and potential supply disruptions from a planned Samsung strike. Retail earnings strength: Target and TJX exceeded forecasts, with robust comparable sales growth in multiple business segments. Biotech boost: Immunovant advanced sharply after reporting positive Phase 2 trial results in difficult-to-treat rheumatoid arthritis.</div>

INTC

IMVT

<p>Semiconductor stocks, including Intel and Micron, rose due to analyst upgrades and AI demand, alongside potential supply disruptions from a Samsung strike. Retailers Target and TJX reported strong earnings, surpassing forecasts with solid sales growth. Biotech firm Immunovant saw significant gains after positive Phase 2 trial results for rheumatoid arthritis.</p>

- The chip sector saw Intel and Micron increase their stock prices due to analyst upgrades, strong AI demand, and potential supply disruptions from a planned Samsung strike.  
- Retailers Target and TJX reported earnings that surpassed forecasts, showing robust growth in comparable sales across various segments.  
- Immunovant's stock rose significantly after it announced positive Phase 2 trial results for its treatment of difficult-to-treat rheumatoid arthritis.

Intel

Micron Tech

Immunovant

Target

Invesco PHLX Semiconductor ETF

VanEck Semiconductor ETF

Invesco Semiconductors ETF

First Trust Nasdaq Food & Semicon

GraniteShares 2x Long MU Daily ETF

GraniteShares 2x Long INTC Daily ETF

SPDR S&P Retail ETF

Direxion Semicon Bull 3X

VanEck Retail ETF

iShares Semiconductor ETF

SPDR S&P Semicon

Semiconductor, retail and biotech stocks climb on sector catalysts